Suppr超能文献

“嗯,我认为存在很大的差异……”:一项关于肿瘤医生在晚期癌症治疗决策中相关医疗标准和其他因素的经验和观点的定性研究。

"Well, I think there is great variation...": a qualitative study of oncologists' experiences and views regarding medical criteria and other factors relevant to treatment decisions in advanced cancer.

机构信息

Institute for Medical Ethics and History of Medicine, Ruhr-Universitaet Bochum, Malakowturm-Markstraße 258a, D-44799 Bochum, Germany.

出版信息

Oncologist. 2013;18(1):90-6. doi: 10.1634/theoncologist.2012-0206. Epub 2013 Jan 3.

Abstract

BACKGROUND

Surveys indicate considerable variation regarding the provision of cancer treatment at the end of life. The variation cannot be fully explained by differences concerning the clinical situation or patients' preferences. The aim of this qualitative study was to explore medical oncologists' experiences with advanced cancer, as well as their views of the relevance of medical and nonmedical criteria for decisions about limiting treatment.

METHODS

Qualitative in-depth interviews were conducted with physicians working in medical oncology in tertiary care hospitals or district general hospitals in England. Purposive sampling and qualitative analysis were performed.

RESULTS

Physicians reported that a number of nonmedical factors influence professional decisions about the offering or limiting of cancer treatment in advanced cancer in addition to medical criteria. Physicians' individual judgments about the benefit of treatment, as well as the amount of their clinical experience, were cited as such factors. In addition, the physicians' perceptions of the patient's age and life circumstances were reported to influence their treatment decisions. Multiprofessional team discussions and the systematic collection of relevant clinical data regarding the outcomes of different treatment approaches in advanced cancer were suggested as strategies to improve the quality of treatment decisions.

CONCLUSION

The findings of this study provide explanations for the variation in treatment in advanced cancer. Making value judgments explicit and gathering more appropriate clinical data on the outcomes of treatment near the end of life are prerequisites for improved ethical and evidence-based treatment decisions in advanced cancer.

摘要

背景

调查表明,在生命末期提供癌症治疗方面存在相当大的差异。这种差异不能完全用临床情况或患者偏好的差异来解释。本 qualitative 研究的目的是探讨医学肿瘤学家对晚期癌症的经验,以及他们对限制治疗的医学和非医学标准的相关性的看法。

方法

在英国的三级保健医院或地区综合医院从事医学肿瘤学工作的医生进行了定性深入访谈。采用目的性抽样和定性分析。

结果

医生报告说,除了医学标准外,还有一些非医学因素会影响他们在晚期癌症中提供或限制癌症治疗的专业决策。医生对治疗益处的个人判断以及他们的临床经验量被认为是此类因素。此外,医生对患者年龄和生活环境的看法也被报道会影响他们的治疗决策。多专业团队讨论和系统收集有关晚期癌症不同治疗方法结果的相关临床数据被认为是改善治疗决策质量的策略。

结论

本研究的结果为晚期癌症治疗中的差异提供了解释。明确价值判断并收集更多关于治疗结局的适当临床数据是改善晚期癌症中伦理和基于证据的治疗决策的前提。

相似文献

10
Paradox of Prescribing Late Chemotherapy: Oncologists Explain.晚期化疗处方的悖论:肿瘤学家解读
J Oncol Pract. 2016 Dec;12(12):e1006-e1015. doi: 10.1200/JOP.2016.013995. Epub 2016 Sep 30.

引用本文的文献

4
Tough Clinical Decisions: Experiences of Polish Physicians.艰难的临床决策:波兰医生的经验。
HEC Forum. 2024 Mar;36(1):111-130. doi: 10.1007/s10730-022-09491-x. Epub 2022 Aug 8.
8
Chemotherapy Use at the End of Life in Uganda.乌干达临终时的化疗使用情况
J Glob Oncol. 2017 Dec;3(6):711-719. doi: 10.1200/JGO.2016.007385. Epub 2017 Jan 18.

本文引用的文献

3
Treatment intensity at end of life--time to act on the evidence.临终时的治疗强度——依据证据采取行动的时机。
Lancet. 2011 Oct 15;378(9800):1364-5. doi: 10.1016/S0140-6736(11)61420-7. Epub 2011 Oct 5.
4
Ethical assessment of life-prolonging treatment.延长生命治疗的伦理评估
Lancet Oncol. 2011 Aug;12(8):720-2. doi: 10.1016/S1470-2045(11)70148-6.
5
Bending the cost curve in cancer care.控制癌症治疗成本
N Engl J Med. 2011 May 26;364(21):2060-5. doi: 10.1056/NEJMsb1013826.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验